human coagulation factor ix
ItalyDrugs containing this active substance
-
It is used to treat and prevent bleeding in people with Hemophilia B (congenital factor IX deficiency) or in subjects with an acquired factor IX deficiency.
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage human coagulation factor ix - ATC: B02BD04
Manufacturer: GRIFOLS ITALIA S.P.A.
-
IXED is used for the treatment and prevention (prophylaxis) of bleeding in patients with hemophilia B (a deficiency of factor IX present from birth) and for the treatment of acquired factor IX deficiency.
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage human coagulation factor ix - ATC: B02BD04
Manufacturer: KEDRION S.P.A.
-
It is used for the treatment and prevention of bleeding in patients with hemophilia B, a condition caused by a hereditary deficiency of coagulation factor IX.
Form: solution for injection, powder and solvent
Active substance Dosage human coagulation factor ix - ATC: B02BD04
Manufacturer: OCTAPHARMA ITALY S.P.A.
-
It is used for the treatment and prevention of bleeding in patients of all ages who have coagulation disorders caused by a deficiency of factors II, IX, and X. It is also indicated for liver diseases, to prevent bleeding after liver biopsies, for infants with coagulation factor deficiencies, and to manage bleeding following the use of certain anticoagulant drugs.
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage coagulation factor ii - human coagulation factor ix - blood coagulation factor x - ATC: B02BD
Manufacturer: BAXALTA INNOVATIONS GMBH
-
It is used for the treatment and prevention of bleeding in patients with hemophilia B (a hereditary coagulation disorder caused by a deficiency of factor IX) of all age groups.
Form: solution for injection, powder and solvent
Active substance Dosage human coagulation factor ix - ATC: B02BD04
Manufacturer: BAXALTA INNOVATIONS GMBH